Susquehanna International Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
207,754
+27,364
| +15% | +$1.46M | ﹤0.01% | 674 |
|
|
2025
Q1 | $7.3M | Buy |
180,390
+145,122
| +411% | +$5.87M | ﹤0.01% | 841 |
|
|
2024
Q4 | $981K | Buy |
35,268
+13,767
| +64% | +$383K | ﹤0.01% | 3015 |
|
|
2024
Q3 | $617K | Sell |
21,501
-13,936
| -39% | -$400K | ﹤0.01% | 3361 |
|
|
2024
Q2 | $831K | Sell |
35,437
-68,683
| -66% | -$1.61M | ﹤0.01% | 2798 |
|
|
2024
Q1 | $2.63M | Buy |
104,120
+82,403
| +379% | +$2.08M | ﹤0.01% | 1525 |
|
|
2023
Q4 | $507K | Sell |
21,717
-329,192
| -94% | -$7.69M | ﹤0.01% | 3842 |
|
|
2023
Q3 | $17.7M | Buy |
350,909
+256,446
| +271% | +$13M | ﹤0.01% | 470 |
|
|
2023
Q2 | $4.41M | Sell |
94,463
-4,240
| -4% | -$198K | ﹤0.01% | 1226 |
|
|
2023
Q1 | $3.78M | Buy |
98,703
+63,149
| +178% | +$2.42M | ﹤0.01% | 1302 |
|
|
2022
Q4 | $1.95M | Sell |
35,554
-37,423
| -51% | -$2.05M | ﹤0.01% | 1614 |
|
|
2022
Q3 | $2.48M | Buy |
+72,977
| New | +$2.48M | ﹤0.01% | 1449 |
|
|
2022
Q2 | – | Sell |
-27,553
| Closed | -$391K | – | 5749 |
|
|
2022
Q1 | $391K | Sell |
27,553
-28,841
| -51% | -$409K | ﹤0.01% | 4017 |
|
|
2021
Q4 | $1.19M | Buy |
56,394
+5,648
| +11% | +$119K | ﹤0.01% | 2624 |
|
|
2021
Q3 | $1.13M | Sell |
50,746
-24,614
| -33% | -$550K | ﹤0.01% | 2611 |
|
|
2021
Q2 | $1.87M | Sell |
75,360
-147,765
| -66% | -$3.67M | ﹤0.01% | 2149 |
|
|
2021
Q1 | $6.47M | Buy |
223,125
+208,854
| +1,463% | +$6.06M | ﹤0.01% | 1046 |
|
|
2020
Q4 | $368K | Sell |
14,271
-8,823
| -38% | -$228K | ﹤0.01% | 3704 |
|
|
2020
Q3 | $711K | Sell |
23,094
-5,093
| -18% | -$157K | ﹤0.01% | 2649 |
|
|
2020
Q2 | $702K | Sell |
28,187
-1,707
| -6% | -$42.5K | ﹤0.01% | 2559 |
|
|
2020
Q1 | $634K | Buy |
+29,894
| New | +$634K | ﹤0.01% | 2599 |
|